HOME
RESOURCE LIBRARY
LEARNING COMMUNITY
FOR PATIENTS
NEWS & EVENTS
News
Event Calendar
Event Recordings
ABOUT
Overview
Quality Initiatives
Practice Map
Team
Contact Us
SPECIALTY CARE
Nephrology
Endocrinology
LEARN
Publications
Care For All
LCD Patient Simulator
The Low Carb Jumpstart
Diabetes Prevention Education
COVERAGE CHECKER
ADMIN PORTAL
PATIENT DATA DASHBOARD

NEWS & EVENTS

NewsEvent CalendarEvent Recordings

ABOUT

OverviewQuality InitiativesPractice MapTeamContact Us

SPECIALTY CARE

NephrologyEndocrinology

LEARN

PublicationsCare For AllLCD Patient SimulatorThe Low Carb JumpstartDiabetes Prevention Education
COVERAGE CHECKER
ADMIN PORTAL
PATIENT DATA DASHBOARD
MCT2D Logo
RESOURCE LIBRARYLEARNING COMMUNITYFOR PATIENTS
Search Icon

Clinician Decision Aid Guideline Directed Medical Therapy for T2D

DOWNLOAD RESOURCE

Updated: 06/15/26

SGLT2 inhibitors and GLP-1 receptor agonists are first-line treatments for T2D in patients with cardiorenal disease. This aid is meant to be used alongside your own clinical judgment, guideline-directed therapy, and prescribing information to guide individualization of diabetes treatment.
Lead clinical author is Heidi Diez, PharmD, clinical pharmacist, with Michael Heung, MD, nephrologist.
MCT2D Newsletter

Subscribe to the Bi-monthly MCT2D Newsletter

We deliver news, updates, events, and more directly to you!

ccteam@mct2d.org

ResourcesPoint of CareMy BookmarksMembersEventsNewsPatientsSpecialty CareNephrologyEndocrinology
AboutOverviewQuality InitiativesJoinTeam
A nonprofit and independent licensee of the Blue Cross Blue Shield Association

Support for The Michigan Collaborative for Type 2 Diabetes (MCT2D) is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program.

Although Blue Cross Blue Shield of Michigan and MCT2D work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs and viewpoints of BCBSM or any of its employees.